Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports
Health Populi
MARCH 13, 2018
Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. Health Populi’s Hot Points: The big wild card in forecasting what prescription drug spending will look like in the U.S.
168 
Let's personalize your content